Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 15, 16:00
2621.80
-30.1 (-1.14%)
VOLUME 3,836
LIVE
NSE
Nov 15, 15:57
2622.85
-25.95 (-0.98%)
VOLUME 96,947
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Profit & Loss account of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 728.24 557.60 535.40 532.67 476.97
Less: Excise/Sevice Tax/Other Levies 0.00 0.99 4.95 6.21 7.92
Revenue From Operations [Net] 728.24 556.61 530.45 526.46 469.05
Other Operating Revenues 0.05 14.39 13.26 37.27 48.02
Total Operating Revenues 728.29 571.00 543.71 563.73 517.07
Other Income 16.29 12.25 14.39 6.77 5.85
Total Revenue 744.58 583.25 558.10 570.50 522.92
EXPENSES
Cost Of Materials Consumed 62.67 27.88 14.01 34.76 26.78
Purchase Of Stock-In Trade 169.84 204.21 141.95 158.89 167.28
Changes In Inventories Of FG,WIP And Stock-In Trade -1.38 -51.00 17.98 5.42 6.01
Employee Benefit Expenses 197.40 153.53 162.04 169.35 159.84
Depreciation And Amortisation Expenses 14.92 14.74 15.83 17.43 15.28
Other Expenses 228.46 190.09 170.79 178.91 168.57
Total Expenses 671.91 539.45 522.60 564.74 543.76
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 72.67 43.80 35.50 5.76 -20.84
Profit/Loss Before Tax 72.67 43.80 35.50 5.76 -20.84
Tax Expenses-Continued Operations
Current Tax 16.68 9.00 8.76 0.50 0.00
Deferred Tax 1.54 8.89 6.69 0.00 0.00
Total Tax Expenses 18.22 17.89 15.45 0.50 0.00
Profit/Loss After Tax And Before ExtraOrdinary Items 54.45 25.91 20.05 5.26 -20.84
Profit/Loss From Continuing Operations 54.45 25.91 20.05 5.26 -20.84
Profit/Loss For The Period 54.45 25.91 20.05 5.26 -20.84
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 21.80 10.40 8.00 2.10 -8.34
Diluted EPS (Rs.) 21.80 10.40 8.00 2.10 -8.34
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 21.66 22.46
Indigenous Raw Materials 0.00 0.00 0.00 13.10 4.32
STORES, SPARES AND LOOSE TOOLS
Indigenous Stores And Spares 0.00 0.00 0.00 2.59 2.89
DIVIDEND AND DIVIDEND PERCENTAGE
Source : Dion Global Solutions Limited

Results of AstraZeneca

  • News
  • Results
  • Estimates
  • Analysis
No news.

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.